Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1745 | 2429 | 26.5 | 52% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MEASLES | Author keyword | 302 | 43% | 22% | 545 |
2 | MEASLES VACCINE | Author keyword | 55 | 45% | 4% | 90 |
3 | MEASLES ELIMINATION | Author keyword | 23 | 79% | 1% | 15 |
4 | BANDIM HLTH PROJECT | Address | 22 | 31% | 2% | 59 |
5 | EDMONSTON ZAGREB | Author keyword | 18 | 89% | 0% | 8 |
6 | MEASLES IMMUNITY | Author keyword | 18 | 89% | 0% | 8 |
7 | MEASLES RUBEOLA | Author keyword | 17 | 70% | 1% | 14 |
8 | MEASLES OUTBREAKS | Author keyword | 17 | 100% | 0% | 8 |
9 | SEX DIFFERENTIAL EFFECTS | Author keyword | 15 | 82% | 0% | 9 |
10 | MEASLES VACCINATION | Author keyword | 15 | 50% | 1% | 21 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MEASLES | 302 | 43% | 22% | 545 | Search MEASLES | Search MEASLES |
2 | MEASLES VACCINE | 55 | 45% | 4% | 90 | Search MEASLES+VACCINE | Search MEASLES+VACCINE |
3 | MEASLES ELIMINATION | 23 | 79% | 1% | 15 | Search MEASLES+ELIMINATION | Search MEASLES+ELIMINATION |
4 | EDMONSTON ZAGREB | 18 | 89% | 0% | 8 | Search EDMONSTON+ZAGREB | Search EDMONSTON+ZAGREB |
5 | MEASLES IMMUNITY | 18 | 89% | 0% | 8 | Search MEASLES+IMMUNITY | Search MEASLES+IMMUNITY |
6 | MEASLES RUBEOLA | 17 | 70% | 1% | 14 | Search MEASLES+RUBEOLA | Search MEASLES+RUBEOLA |
7 | MEASLES OUTBREAKS | 17 | 100% | 0% | 8 | Search MEASLES+OUTBREAKS | Search MEASLES+OUTBREAKS |
8 | SEX DIFFERENTIAL EFFECTS | 15 | 82% | 0% | 9 | Search SEX+DIFFERENTIAL+EFFECTS | Search SEX+DIFFERENTIAL+EFFECTS |
9 | MEASLES VACCINATION | 15 | 50% | 1% | 21 | Search MEASLES+VACCINATION | Search MEASLES+VACCINATION |
10 | MEASLES OUTBREAK | 13 | 80% | 0% | 8 | Search MEASLES+OUTBREAK | Search MEASLES+OUTBREAK |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RUBELLA | 63 | 28% | 8% | 194 |
2 | EDMONSTON ZAGREB | 61 | 65% | 2% | 58 |
3 | MUMPS | 37 | 21% | 7% | 161 |
4 | FEMALE MALE MORTALITY | 35 | 67% | 1% | 32 |
5 | SCHOOL POPULATION | 34 | 54% | 2% | 44 |
6 | SUCCESSFUL IMMUNIZATION | 33 | 77% | 1% | 23 |
7 | DIPLOID CELL | 30 | 100% | 0% | 12 |
8 | LATE CONVALESCENT | 20 | 100% | 0% | 9 |
9 | ROUTINE VACCINATIONS | 19 | 37% | 2% | 42 |
10 | AEROSOLIZED MEASLES | 18 | 83% | 0% | 10 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Measles associated with international travel in the region of the Americas, Australia and Europe, 2001-2013: A systematic review | 2015 | 2 | 26 | 62% |
Nosocomial transmission of measles: An updated review | 2012 | 24 | 32 | 88% |
Molecular Epidemiology of Measles Virus | 2009 | 57 | 87 | 72% |
Is early measles vaccination better than later measles vaccination? | 2015 | 1 | 47 | 89% |
Immunogenicity and safety of aerosolized measles vaccine: Systematic review and meta-analysis | 2008 | 44 | 23 | 74% |
A small jab - a big effect: nonspecific immunomodulation by vaccines | 2013 | 28 | 77 | 30% |
Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns | 2007 | 46 | 52 | 69% |
The clinical significance of measles: A review | 2004 | 107 | 126 | 52% |
Measles: Not just a childhood rash | 2010 | 19 | 20 | 80% |
Measles - The epidemiology of elimination | 2014 | 4 | 22 | 77% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BANDIM HLTH PROJECT | 22 | 31% | 2.4% | 59 |
2 | GLOBAL IMMUNIZAT | 13 | 21% | 2.3% | 55 |
3 | EXPANDED PROGRAMME IMMUNIZAT | 12 | 31% | 1.4% | 33 |
4 | VITAMINS VACCINES CVIVA | 10 | 40% | 0.8% | 19 |
5 | MEASLES VIRUS SECT | 9 | 55% | 0.5% | 12 |
6 | REFERENCE MEASLES RUBELLA | 9 | 83% | 0.2% | 5 |
7 | GLOBAL MEASLES BRANCH | 8 | 70% | 0.3% | 7 |
8 | ABORATING MEASLES | 8 | 75% | 0.2% | 6 |
9 | REFERENCE MEASLES MUMPS RUBELLA | 8 | 75% | 0.2% | 6 |
10 | GLOBAL REFERENCE MEASLES | 8 | 100% | 0.2% | 5 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000200107 | MUMPS VIRUS//MUMPS//MUMPS VACCINE |
2 | 0.0000182640 | MEASLES VIRUS//SSPE VIRUS//VIROL IMMUNOBIOL |
3 | 0.0000131400 | CONGENITAL RUBELLA SYNDROME//RUBELLA VIRUS//RUBELLA |
4 | 0.0000110556 | IMMUNIZAT PROGRAM//IMMUNIZATION//VACCINE HESITANCY |
5 | 0.0000109007 | SUBACUTE SCLEROSING PANENCEPHALITIS//SSPE//SUBACUTE SCLEROSING PANENCEPHALITIS SSPE |
6 | 0.0000090471 | PROGRAM TRANSLAT IMMUNOVIROL BIODEF//MAYO VACCINE GRP//MAYO CLIN VACCINE GRP |
7 | 0.0000079820 | FLUOROSCEIN ISOTHIOCYANATE//INFLUENZA A H1N12009//LUCIFER YELLOW CARBOHYDRAZIDE |
8 | 0.0000060813 | LOT QUALITY ASSURANCE SAMPLING//LQAS//LOT QUALITY ASSURANCE SAMPLING LQAS |
9 | 0.0000055015 | C18L GENE//GO GENE ONTOLOGY//KEGG KYOTO ENCYCLOPEDIA OF GENES AND GENOMES |
10 | 0.0000054355 | ICES UOTTAWA//VACCINATION AGE//TUBERCULIN RESPONSE |